SVP and Chief Legal Officer of Essent Group Ltd. (NYSE:ESNT), Gibbons Mary Lourdes, sells 1,400 shares worth $67,200
According to Essent Group Ltd. s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 12 07:51 AM, company SVP and Chief Legal Officer, Gibbons Mary Lourdes disclosed selling 1,400 shares at a cost of $48.00. At the time of this transaction (Jan 08), this trade was worth $67,200 in total. As of Jan 08, Gibbons Mary Lourdes now owns 210,012 shares in total worth about $10,357,791.84.
For the last few recent trades made by Essent Group Ltd. (NYSE:ESNT) SVP and Chief Legal Officer, Gibbons Mary Lourdes, we have the following information:
SVP and Chief Legal Officer of Essent Group Ltd (NYSE:ESNT), Gibbons Mary Lourdes, sells 5,000 shares worth 0,450
empowerednews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from empowerednews.net Daily Mail and Mail on Sunday newspapers.
SVP and Chief Legal Officer of Essent Group Ltd. (NYSE:ESNT), Gibbons Mary Lourdes, sells 3,850 shares worth $185,147
According to Essent Group Ltd. s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 12 07:51 AM, company SVP and Chief Legal Officer, Gibbons Mary Lourdes disclosed selling 3,850 shares at a cost of $48.09. At the time of this transaction (Jan 11), this trade was worth $185,147 in total. As of Jan 11, Gibbons Mary Lourdes now owns 206,162 shares in total worth about $10,167,909.84.
For the last few recent trades made by Essent Group Ltd. (NYSE:ESNT) SVP and Chief Legal Officer, Gibbons Mary Lourdes, we have the following information:
CEO and President of Jounce Therapeutics, Inc. (NASDAQ:JNCE), Murray Richard /Ca/, sells 11,816 shares worth $82,712
According to Jounce Therapeutics, Inc. s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 11 06:21 AM, company CEO and President, Murray Richard /Ca/ disclosed selling 11,816 shares at a cost of $7.00. At the time of this transaction (Jan 08), this trade was worth $82,712 in total. As of Jan 08, Murray Richard /Ca/ now owns 140,371 shares in total worth about $1,026,112.0099999999.
For the last few recent trades made by Jounce Therapeutics, Inc. (NASDAQ:JNCE) CEO and President, Murray Richard /Ca/, we have the following information:
CEO and President of Jounce Therapeutics, Inc. (NASDAQ:JNCE), Murray Richard /Ca/, sells 10,183 shares worth $68,837
According to Jounce Therapeutics, Inc. s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 11 06:21 AM, company CEO and President, Murray Richard /Ca/ disclosed selling 10,183 shares at a cost of $6.76. At the time of this transaction (Jan 07), this trade was worth $68,837 in total. As of Jan 07, Murray Richard /Ca/ now owns 152,187 shares in total worth about $1,112,486.97.
For the last few recent trades made by Jounce Therapeutics, Inc. (NASDAQ:JNCE) CEO and President, Murray Richard /Ca/, we have the following information:
vimarsana © 2020. All Rights Reserved.